Infections post transplant: Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 29, Issue 7, 2002, Pages 589-594

  Frere P ^a   Hermanne, J P ^a   Debouge, M H ^a   Fillet, G ^a   Beguin, Y ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Antibiotics; Bacterial infection; Bone marrow transplantation

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; OXACILLIN; PIPERACILLIN; QUINOLONE; TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ALLOGRAFT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUTOGRAFT; BACTERIAL COLONIZATION; BLOOD CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; ENTEROBACTER; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; BELGIUM; CARBAPENEMS; CEPHALOSPORINS; CIPROFLOXACIN; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS; STREPTOCOCCUS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036099938     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/bmt/1703413     Document Type: Article

References (26)

1. An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia
2. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
3. Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies
4. Prophylaxis of infection in neutropenic patients. Guidelines of the working party on infections in hematology and oncology
5. Antibacterial prophylaxis
6. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: A reappraisal
7. Monotherapy with meropenem versus combination therapy with ceftazidim plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
8. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-amynoglycoside combination regimens in the empirical treatment of serious bacterial infections
9. A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy
10. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation
11. An open, randomized, multicentre study comparing the use of low-dose ceftazidim or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients
12. Pression de sélection et résistance bactérienne à l'hôpital
13. Exposition aux antibiotiques et sélection de résistance: Données cliniques
14. Antimicrobial resistance in Enterobacteriaceae in Brooklyn NY: Epidemiology and relation to antibiotic usage patterns
15. High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey
16. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms
17. Epidemiology of antibiotic resistance
18. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998
19. Isolation of beta-lactamase positive vancomycin resistant Enterococcus faecalis; first case in Australia
20. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions
21. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid
22. Problems and perils of vancomycin resistant enterococci
23. Perspectives on the development of new antimicrobial agents for resistant gram-positive pathogens
24. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis
25. Sélection de résistance sous la pression des nouveaux antibiotiques
26. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients